Fennec Pharmaceuticals (FENC) Change in Accured Expenses (2014 - 2025)

Fennec Pharmaceuticals (FENC) has 12 years of Change in Accured Expenses data on file, last reported at $1.9 million in Q4 2025.

• Quarterly Change in Accured Expenses rose 1581.74% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 776.99% YoY) and the FY2025 annual result came in at $2.2 million, up 776.99% from the prior year.
• Change in Accured Expenses advanced to $1.9 million in Q4 2025, from $1.5 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.9 million in Q4 2025 to a low of -$1.3 million in Q2 2024.
• A 5-year average of $195000.0 and a median of -$29000.0 in 2021 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 10635.29% — and 2024, when it tumbled 1666.67%.
• Tracing FENC's Change in Accured Expenses over 5 years: stood at $17000.0 in 2021, then soared by 10635.29% to $1.8 million in 2022, then increased by 1.1% to $1.8 million in 2023, then plunged by 93.77% to $115000.0 in 2024, then jumped by 1581.74% to $1.9 million in 2025.
• The last three Change in Accured Expenses figures came in at $1.9 million (Q4 2025), $1.5 million (Q3 2025), and -$618000.0 (Q2 2025), per Business Quant data.